Virios Therapeutics (NASDAQ:VIRI) Stock Price Up 0.8% – Time to Buy?

Virios Therapeutics, Inc. (NASDAQ:VIRI)’s stock price traded up 0.8% during mid-day trading on Friday . The company traded as high as $2.60 and last traded at $2.51. 22,306 shares were traded during trading, a decline of 98% from the average session volume of 1,049,645 shares. The stock had previously closed at $2.49.

Analysts Set New Price Targets

Separately, HC Wainwright boosted their price target on shares of Virios Therapeutics from $0.20 to $5.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th.

Virios Therapeutics Trading Up 4.0 %

The company has a fifty day moving average of $3.02 and a 200-day moving average of $1.53. The company has a market capitalization of $50.26 million, a price-to-earnings ratio of -9.67 and a beta of 1.58.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.